Discovery of GLPG3667, a Selective ATP Competitive Tyrosine Kinase 2 Inhibitor for the Treatment of Autoimmune Diseases.
Mammoliti O, Martina S, Claes P, Coti G, Blanque R, Jagerschmidt C, Shoji K, Borgonovi M, De Vos S, Marsais F, Oste L, Quinton E, López-Ramos M, Amantini D, Brys R, Jimenez JM, Galien R, van der Plas S.
Mammoliti O, et al. Among authors: shoji k.
J Med Chem. 2024 May 28. doi: 10.1021/acs.jmedchem.4c00769. Online ahead of print.
J Med Chem. 2024.
PMID: 38805213